SMYD3 and ovarian cancer: SMYD3 promotes ovarian cancer proliferation and interferes with apoptosis in vitro and in vivo by regulating cell cycle checkpoints and apoptosis-related proteins though SMYD3-H4K20me3-CDKN2A pathway and SMYD3-H3K4me3-BIRC3 pathway.